AIKI Annual CFF
$78.30 M
+$46.70 M+147.73%
31 December 2021
Summary:
As of February 5, 2025, AIKI annual cash flow from financing activities is $78.30 million, with the most recent change of +$46.70 million (+147.73%) on December 31, 2021. During the last 3 years, it has risen by +$75.60 million (+2800.11%).AIKI Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AIKI Quarterly CFF
-$751.00 K
+$23.86 M+96.95%
30 September 2022
Summary:
As of February 5, 2025, AIKI quarterly cash flow from financing activities is -$751.00 thousand, with the most recent change of +$23.86 million (+96.95%) on September 30, 2022. Over the past year, it has dropped by -$751.00 thousand (-100.00%).AIKI Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AIKI TTM CFF
-$6.14 M
-$751.00 K-13.93%
30 September 2022
Summary:
As of February 5, 2025, AIKI TTM cash flow from financing activities is -$6.14 million, with the most recent change of -$751.00 thousand (-13.93%) on September 30, 2022. Over the past year, it has dropped by -$84.22 million (-107.87%).AIKI TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AIKI Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +147.7% | -100.0% | -107.9% |
| 3 y3 years | +2800.1% | -243.6% | -434.7% |
| 5 y5 years | +3680.9% | -135.8% | -434.7% |
AIKI Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | at high | -101.0% | -106.8% |
AIkido Pharma Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$751.00 K(-96.9%) | -$6.14 M(+13.9%) |
| June 2022 | - | -$24.61 M(-229.6%) | -$5.39 M(-128.0%) |
| Mar 2022 | - | $18.99 M(+8157.0%) | $19.22 M(-75.5%) |
| Dec 2021 | $78.30 M(+147.7%) | $230.00 K(>+9900.0%) | $78.30 M(+0.3%) |
| Sept 2021 | - | $0.00(0.0%) | $78.07 M(0.0%) |
| June 2021 | - | $0.00(-100.0%) | $78.07 M(-14.1%) |
| Mar 2021 | - | $78.07 M(>+9900.0%) | $90.90 M(+187.6%) |
| Dec 2020 | $31.61 M(+1622.5%) | $0.00(0.0%) | $31.61 M(-1.6%) |
| Sept 2020 | - | $0.00(-100.0%) | $32.13 M(-1.6%) |
| June 2020 | - | $12.82 M(-31.7%) | $32.66 M(+58.4%) |
| Mar 2020 | - | $18.78 M(+3477.7%) | $20.62 M(+1023.6%) |
| Dec 2019 | $1.83 M(-32.0%) | $525.00 K(+0.4%) | $1.83 M(+40.1%) |
| Sept 2019 | - | $523.00 K(-33.5%) | $1.31 M(+66.5%) |
| June 2019 | - | $787.00 K(>+9900.0%) | $787.00 K(>+9900.0%) |
| Mar 2019 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2018 | $2.70 M(+30.4%) | $0.00(0.0%) | $2.70 M(0.0%) |
| Sept 2018 | - | $0.00(0.0%) | $2.70 M(-43.7%) |
| June 2018 | - | $0.00(-100.0%) | $4.79 M(+0.5%) |
| Mar 2018 | - | $2.70 M(>+9900.0%) | $4.77 M(+130.4%) |
| Dec 2017 | $2.07 M(-28.5%) | $0.00(-100.0%) | $2.07 M(0.0%) |
| Sept 2017 | - | $2.10 M(-8829.2%) | $2.07 M(-2.1%) |
| June 2017 | - | -$24.00 K(<-9900.0%) | $2.12 M(-26.9%) |
| Mar 2017 | - | $0.00(0.0%) | $2.90 M(0.0%) |
| Dec 2016 | $2.90 M(-24.4%) | $0.00(-100.0%) | $2.90 M(-54.3%) |
| Sept 2016 | - | $2.14 M(+183.1%) | $6.34 M(+14.8%) |
| June 2016 | - | $756.00 K(-78.1%) | $5.52 M(+44.1%) |
| Dec 2015 | $3.83 M(-53.2%) | $3.45 M(+160.9%) | $3.83 M(+892.7%) |
| Sept 2015 | - | $1.32 M(-241.3%) | $386.00 K(-136.9%) |
| June 2015 | - | -$935.00 K(<-9900.0%) | -$1.04 M(-112.8%) |
| Dec 2014 | $8.20 M(+153.4%) | $0.00(-100.0%) | $8.20 M(-21.4%) |
| Sept 2014 | - | -$110.00 K(-102.5%) | $10.43 M(-5.5%) |
| June 2014 | - | $4.41 M(+13.0%) | $11.04 M(+54.7%) |
| Mar 2014 | - | $3.90 M(+74.5%) | $7.13 M(+120.6%) |
| Dec 2013 | $3.23 M(-4.9%) | $2.23 M(+347.0%) | $3.23 M(-3.3%) |
| Sept 2013 | - | $500.00 K(0.0%) | $3.35 M(+17.6%) |
| June 2013 | - | $500.00 K(>+9900.0%) | $2.84 M(+21.9%) |
| Mar 2013 | - | $0.00(-100.0%) | $2.33 M(-31.4%) |
| Dec 2012 | $3.40 M(-8.1%) | $2.35 M(<-9900.0%) | $3.40 M(+53.9%) |
| Sept 2012 | - | -$1700.00(-84.0%) | $2.21 M(-0.1%) |
| June 2012 | - | -$10.60 K(-101.0%) | $2.21 M(-0.5%) |
| Mar 2012 | - | $1.07 M(-7.7%) | $2.22 M(-40.0%) |
| Dec 2011 | $3.70 M(-24.0%) | $1.16 M(>+9900.0%) | $3.70 M(-50.1%) |
| Sept 2011 | - | $0.00(-100.0%) | $7.41 M(0.0%) |
| June 2011 | - | -$200.00(-100.0%) | $7.41 M(-0.0%) |
| Mar 2011 | - | $2.55 M(-47.7%) | $7.41 M(+52.3%) |
| Dec 2010 | $4.87 M(-18.0%) | $4.87 M(>+9900.0%) | $4.87 M(-18.0%) |
| Sept 2010 | - | $0.00(0.0%) | $5.93 M(0.0%) |
| June 2010 | - | $0.00(0.0%) | $5.93 M(0.0%) |
| Mar 2010 | - | $0.00(-100.0%) | $5.93 M(0.0%) |
| Dec 2009 | $5.93 M(<-9900.0%) | $5.93 M(>+9900.0%) | $5.93 M(-7189.2%) |
| June 2009 | - | $0.00(0.0%) | -$83.70 K(+151.4%) |
| Dec 2008 | -$33.30 K(-105.1%) | $0.00(-100.0%) | -$33.30 K(+254.3%) |
| Sept 2008 | - | -$83.70 K(-413.5%) | -$9400.00(-84.9%) |
| June 2008 | - | $26.70 K(+12.7%) | -$62.10 K(-82.0%) |
| Mar 2008 | - | $23.70 K(-0.8%) | -$344.70 K(-152.6%) |
| Dec 2007 | $655.60 K(-36.9%) | $23.90 K(-117.5%) | $655.70 K(+4.1%) |
| Sept 2007 | - | -$136.40 K(-46.7%) | $630.10 K(-9.4%) |
| June 2007 | - | -$255.90 K(-125.0%) | $695.30 K(-205.3%) |
| Mar 2007 | - | $1.02 M(<-9900.0%) | -$660.50 K(-163.5%) |
| Dec 2006 | $1.04 M(+175.9%) | -$1700.00(-97.6%) | $1.04 M(-22.3%) |
| Sept 2006 | - | -$71.20 K(-95.6%) | $1.34 M(+0.3%) |
| June 2006 | - | -$1.61 M(-159.2%) | $1.33 M(-60.3%) |
| Mar 2006 | - | $2.72 M(+818.5%) | $3.36 M(+791.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2005 | $376.90 K(-89.3%) | $296.60 K(-492.3%) | $376.90 K(-307.3%) |
| Sept 2005 | - | -$75.60 K(-118.2%) | -$181.80 K(-68.2%) |
| June 2005 | - | $416.00 K(-259.9%) | -$572.00 K(-47.5%) |
| Mar 2005 | - | -$260.10 K(-0.8%) | -$1.09 M(-131.0%) |
| Dec 2004 | $3.51 M(+180.2%) | -$262.10 K(-43.7%) | $3.51 M(-54.8%) |
| Sept 2004 | - | -$465.80 K(+361.6%) | $7.78 M(+3.1%) |
| June 2004 | - | -$100.90 K(-102.3%) | $7.54 M(+49.0%) |
| Mar 2004 | - | $4.34 M(+8.6%) | $5.06 M(+303.9%) |
| Dec 2003 | $1.25 M(-73.0%) | $4.00 M(-672.8%) | $1.25 M(-159.2%) |
| Sept 2003 | - | -$698.30 K(-72.9%) | -$2.12 M(+39.4%) |
| June 2003 | - | -$2.58 M(-584.5%) | -$1.52 M(-227.2%) |
| Mar 2003 | - | $532.60 K(-15.4%) | $1.19 M(-74.3%) |
| Dec 2002 | $4.65 M(-3822.2%) | $629.80 K(-727.3%) | $4.65 M(+17.6%) |
| Sept 2002 | - | -$100.40 K(-176.2%) | $3.95 M(+28.3%) |
| June 2002 | - | $131.70 K(-96.7%) | $3.08 M(-33.8%) |
| Mar 2002 | - | $3.98 M(-6064.4%) | $4.64 M(-3824.5%) |
| Dec 2001 | -$124.80 K(-102.9%) | -$66.80 K(-93.1%) | -$124.70 K(-135.1%) |
| Sept 2001 | - | -$972.30 K(-157.2%) | $355.00 K(-65.9%) |
| June 2001 | - | $1.70 M(-316.5%) | $1.04 M(-154.1%) |
| Mar 2001 | - | -$784.90 K(-290.1%) | -$1.92 M(-144.4%) |
| Dec 2000 | $4.33 M(+154.8%) | $412.90 K(-244.6%) | $4.33 M(+7.8%) |
| Sept 2000 | - | -$285.60 K(-77.5%) | $4.02 M(+14.3%) |
| June 2000 | - | -$1.27 M(-123.2%) | $3.52 M(-44.8%) |
| Mar 2000 | - | $5.47 M(+5371.7%) | $6.37 M(+274.8%) |
| Dec 1999 | $1.70 M(-19.0%) | $100.00 K(-112.7%) | $1.70 M(-5.6%) |
| Sept 1999 | - | -$787.40 K(-149.6%) | $1.80 M(-21.3%) |
| June 1999 | - | $1.59 M(+98.4%) | $2.29 M(+8.9%) |
| Mar 1999 | - | $800.00 K(+300.0%) | $2.10 M(0.0%) |
| Dec 1998 | $2.10 M(-40.0%) | $200.00 K(-166.7%) | $2.10 M(-59.6%) |
| Sept 1998 | - | -$300.00 K(-121.4%) | $5.20 M(-3.7%) |
| June 1998 | - | $1.40 M(+75.0%) | $5.40 M(+38.5%) |
| Mar 1998 | - | $800.00 K(-75.8%) | $3.90 M(+11.4%) |
| Dec 1997 | $3.50 M(+600.0%) | $3.30 M(-3400.0%) | $3.50 M(+250.0%) |
| Sept 1997 | - | -$100.00 K(0.0%) | $1.00 M(+400.0%) |
| June 1997 | - | -$100.00 K(-125.0%) | $200.00 K(-81.8%) |
| Mar 1997 | - | $400.00 K(-50.0%) | $1.10 M(+120.0%) |
| Dec 1996 | $500.00 K(-155.6%) | $800.00 K(-188.9%) | $500.00 K(-225.0%) |
| Sept 1996 | - | -$900.00 K(-212.5%) | -$400.00 K(-200.0%) |
| June 1996 | - | $800.00 K(-500.0%) | $400.00 K(-150.0%) |
| Mar 1996 | - | -$200.00 K(+100.0%) | -$800.00 K(-11.1%) |
| Dec 1995 | -$900.00 K(+800.0%) | -$100.00 K(0.0%) | -$900.00 K(+12.5%) |
| Sept 1995 | - | -$100.00 K(-75.0%) | -$800.00 K(+14.3%) |
| June 1995 | - | -$400.00 K(+33.3%) | -$700.00 K(+133.3%) |
| Mar 1995 | - | -$300.00 K(<-9900.0%) | -$300.00 K(<-9900.0%) |
| Dec 1994 | -$100.00 K(-110.0%) | - | - |
| June 1994 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| Mar 1994 | - | -$200.00 K(<-9900.0%) | -$100.00 K(-110.0%) |
| Dec 1993 | $1.00 M(-211.1%) | $0.00(-100.0%) | $1.00 M(+42.9%) |
| Sept 1993 | - | $200.00 K(-300.0%) | $700.00 K(+75.0%) |
| June 1993 | - | -$100.00 K(-111.1%) | $400.00 K(+100.0%) |
| Mar 1993 | - | $900.00 K(-400.0%) | $200.00 K(-122.2%) |
| Dec 1992 | -$900.00 K(+350.0%) | -$300.00 K(+200.0%) | -$900.00 K(+80.0%) |
| Sept 1992 | - | -$100.00 K(-66.7%) | -$500.00 K(-61.5%) |
| June 1992 | - | -$300.00 K(+50.0%) | -$1.30 M(+225.0%) |
| Mar 1992 | - | -$200.00 K(-300.0%) | -$400.00 K(+100.0%) |
| Dec 1991 | -$200.00 K(<-9900.0%) | $100.00 K(-111.1%) | -$200.00 K(-80.0%) |
| Sept 1991 | - | -$900.00 K(-250.0%) | -$1.00 M(<-9900.0%) |
| June 1991 | - | $600.00 K(>+9900.0%) | $0.00(-100.0%) |
| Mar 1991 | - | $0.00(-100.0%) | -$400.00 K(<-9900.0%) |
| Dec 1990 | $0.00 | -$700.00 K(-800.0%) | $0.00(-100.0%) |
| Sept 1990 | - | $100.00 K(-50.0%) | $700.00 K(+16.7%) |
| June 1990 | - | $200.00 K(-50.0%) | $600.00 K(+50.0%) |
| Mar 1990 | - | $400.00 K | $400.00 K |
FAQ
- What is AIkido Pharma annual cash flow from financing activities?
- What is the all time high annual CFF for AIkido Pharma?
- What is AIkido Pharma annual CFF year-on-year change?
- What is AIkido Pharma quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for AIkido Pharma?
- What is AIkido Pharma quarterly CFF year-on-year change?
- What is AIkido Pharma TTM cash flow from financing activities?
- What is the all time high TTM CFF for AIkido Pharma?
- What is AIkido Pharma TTM CFF year-on-year change?
What is AIkido Pharma annual cash flow from financing activities?
The current annual CFF of AIKI is $78.30 M
What is the all time high annual CFF for AIkido Pharma?
AIkido Pharma all-time high annual cash flow from financing activities is $78.30 M
What is AIkido Pharma annual CFF year-on-year change?
Over the past year, AIKI annual cash flow from financing activities has changed by +$46.70 M (+147.73%)
What is AIkido Pharma quarterly cash flow from financing activities?
The current quarterly CFF of AIKI is -$751.00 K
What is the all time high quarterly CFF for AIkido Pharma?
AIkido Pharma all-time high quarterly cash flow from financing activities is $78.07 M
What is AIkido Pharma quarterly CFF year-on-year change?
Over the past year, AIKI quarterly cash flow from financing activities has changed by -$751.00 K (-100.00%)
What is AIkido Pharma TTM cash flow from financing activities?
The current TTM CFF of AIKI is -$6.14 M
What is the all time high TTM CFF for AIkido Pharma?
AIkido Pharma all-time high TTM cash flow from financing activities is $90.90 M
What is AIkido Pharma TTM CFF year-on-year change?
Over the past year, AIKI TTM cash flow from financing activities has changed by -$84.22 M (-107.87%)